Global NAC (Acetylcysteine) Market Growth 2025-2031

The global NAC (Acetylcysteine) market size is predicted to grow from US$ 123 million in 2025 to US$ 198 million in 2031; it is expected to grow at a CAGR of 8.3% from 2025 to 2031.

Acetylcysteine, also known as N-acetylcysteine (NAC), is a modified amino acid that is used as an antidote for acetaminophen overdose to prevent hepatic injury. Acetylcysteine is a hepatoprotective agent and has not been linked to significant serum enzyme elevations during therapy or to instances of clinically apparent acute liver injury.

Global 3 key players of Acetylcysteine are Zambon, Axplora (Pharmazell) and Wuhan Grand Hoyo, with about 64% market shares. Europe is the largest market, which has a share about 47%, followed by Asia-Pacific and North America, with share 32% and 18%, respectively. In terms of product type, effervescent tablets is the largest segment, accounting for a share of 28%. And in terms of application, medicine is the largest, followed by nutritional Supplements.

ReportPrime, Inc. (LPI)'s newest research report, the “NAC (Acetylcysteine) Industry Forecast” looks at past sales and reviews total world NAC (Acetylcysteine) sales in 2024, providing a comprehensive analysis by region and market sector of projected NAC (Acetylcysteine) sales for 2025 through 2031. With NAC (Acetylcysteine) sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world NAC (Acetylcysteine) industry.

This Insight Report provides a comprehensive analysis of the global NAC (Acetylcysteine) landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on NAC (Acetylcysteine) portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global NAC (Acetylcysteine) market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for NAC (Acetylcysteine) and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global NAC (Acetylcysteine).

This report presents a comprehensive overview, market shares, and growth opportunities of NAC (Acetylcysteine) market by product type, application, key manufacturers and key regions and countries.

• Segmentation by Type:
• Injection
• Granule for Oral Solution
• Oral Inhalation
• Effervescent Tablets
• Others

• Segmentation by Application:
• Medicine
• Nutritional Supplements
• Others

• Market by region:
• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia

Europe

• Germany
• France
• UK
• Italy
• Russia

Middle East & Africa

• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

• Company’s coverage:
• Zambon
• Moehs
• Axplora (Pharmazell)
• Nippon Rika
• Chengyi Pharma
• Wuhan Grand Hoyo
• Manus Aktteva Biopharma
• Shine Star Biological
• Huachang Pharmaceutical
• Xinhanling Biological
• Shuguang Biological

Key Questions Addressed in this Report:

• What is the 10-year outlook for the global NAC (Acetylcysteine) market?
• What factors are driving NAC (Acetylcysteine) market growth, globally and by region?
• Which technologies are poised for the fastest growth by market and region?
• How do NAC (Acetylcysteine) market opportunities vary by end market size?
• How does NAC (Acetylcysteine) break out by Type, by Application?